Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents

Por Yu, Dongke, Cai, Shi-Ying, Mennone, Albert, Vig, Pamela, Boyer, James L.
Publicado no Liver Int (2018)

Pharmacological inhibition of CCR2/5 signaling prevents and reverses alcohol-induced liver damage, steatosis and inflammation in mice

Por Ambade, Aditya, Lowe, Patrick, Kodys, Karen, Catalano, Donna, Gyongyosi, Benedek, Cho, Yeonhee, Vellve, Arvin-Iracheta, Adejumo, Adeyinka, Saha, Banishree, Calenda, Charles, Mehta, Jeeval, Lefebvre, Eric, Vig, Pamela, Szabo, Gyongyi
Publicado no Hepatology (2019)

The Critical Role of Chemokine (C–C Motif) Receptor 2-Positive Monocytes in Autoimmune Cholangitis

Por Reuveni, Debby, Gore, Yael, Leung, Patrick S. C., Lichter, Yael, Moshkovits, Itay, Kaminitz, Ayelet, Brazowski, Eli, Lefebvre, Eric, Vig, Pamela, Varol, Chen, Halpern, Zamir, Shibolet, Oren, Gershwin, Merrill Eric, Zigmond, Ehud
Publicado no Front Immunol (2018)

Macrophages Contribute to the Pathogenesis of Sclerosing Cholangitis in Mice

Por Guicciardi, Maria Eugenia, Trussoni, Christy E., Krishnan, Anuradha, Bronk, Steven F., Lorenzo Pisarello, Maria J., O’Hara, Steven P., Splinter, Patrick L., Gao, Yandong, Vig, Pamela, Revzin, Alexander, LaRusso, Nicholas F., Gores, Gregory J.
Publicado no J Hepatol (2018)

A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

Por Friedman, Scott L., Ratziu, Vlad, Harrison, Stephen A., Abdelmalek, Manal F., Aithal, Guruprasad P., Caballeria, Juan, Francque, Sven, Farrell, Geoffrey, Kowdley, Kris V., Craxi, Antonio, Simon, Krzysztof, Fischer, Laurent, Melchor‐Khan, Liza, Vest, Jeffrey, Wiens, Brian L., Vig, Pamela, Seyedkazemi, Star, Goodman, Zachary, Wong, Vincent Wai‐Sun, Loomba, Rohit, Tacke, Frank, Sanyal, Arun, Lefebvre, Eric
Publicado no Hepatology (2018)